Inflammatory Breast Cancer

Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer

Translate to Spanish or other 102 languages!

Inflammatory breast cancer (IBC) is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. Image for illustration purposes
Inflammatory breast cancer (IBC) is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. Image for illustration purposes

Mega Doctor News

- Advertisement -

By American Cancer Society (ACS) 

Newswise — Inflammatory breast cancer (IBC) is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society (ACS) is highlighting IBC to help women be aware of this invasive cancer.

“IBC is tricky as it doesn’t usually present with a breast lump like many women expect when they think of a breast cancer. Instead, the disease causes inflammatory symptoms, like swelling and redness as cancer cells block lymph vessels in the skin,” said Dr. William Dahut, chief scientific officer at the American Cancer Society. “These symptoms may show up quickly – over just three to six months, so if you experience them, it is important to investigate with your healthcare team right away.”

- Advertisement -

Also concerning, IBC may not show up on a mammogram, and it can grow and spread more quickly than other forms of breast cancer. Because of this and because it involves the skin, all cases of IBC are considered advanced to at least Stage III when first diagnosed, and in about one-third of cases, the cancer has spread to distant parts of the body when it is diagnosed.

Women at risk for IBC include:

  • Women under 40 years old
  • Black women
  • Women who are overweight or obese

Warning signs for IBC include:

  • Swelling (edema) of the skin of the breast
  • Redness involving more than one-third of the breast
  • Pitting or thickening of the skin of the breast so that it may look and feel like an orange peel
  • A retracted or inverted nipple
  • One breast looks larger than the other
  • One breast feels warmer and heavier than the other breast
  • A breast that may be tender, painful, or itchy
  • Swelling of the lymph nodes under the arms or near the collarbone

Some of those symptoms can also be signs of an infection, so a doctor may at first treat a patient with antibiotics. If symptoms don’t clear within 7 to 10 days of antibiotic treatment, more tests must be done to check for cancer or other problems. IBC should be considered as a stronger possibility if a woman with symptoms is not pregnant or breastfeeding or has already gone through menopause.

- Advertisement -

Diagnosis of IBC typically involves imaging tests, like a mammogram, breast ultrasound, or breast MRI, and always includes a biopsy, where a small piece of breast tissue is removed and evaluated in a lab.

If IBC has not spread beyond the breast, treatment usually includes chemotherapy first, followed by surgery to remove the cancer. Radiation and other more targeted drug therapies are given after surgery. If IBC has spread to other body parts, it is treated with chemotherapy, hormone therapy, and targeted drug therapy.

“There is encouraging news in the form of new drugs and treatment combinations for IBC,” added Dahut. “Specific drug combinations or combinations of drugs and radiation therapy are being tested to help keep the cancer from returning. For advanced disease, treatments that include new targeted therapies are being studied and certain immunotherapy drugs have already been approved for treatment of IBC that is triple negative.”

Learn more about IBC at cancer.org/inflammatorybreastcancer.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -